PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
03-Jun-2020 Clinerion gains ISO/IEC 15504 (SPICE) certification. Clinerion Ltd.
02-Jun-2020 Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19 Gilead
02-Jun-2020 Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans Eli Lilly and Company
01-Jun-2020 Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline Daiichi Sankyo, Inc.
01-Jun-2020 Sanofi announces closing of Regeneron stock sale Sanofi
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA Chi-Med
01-Jun-2020 Immutep announces improving data from the phase II TACTI-002 study Immutep
01-Jun-2020 Immutep reports first results from INSIGHT-004 study Immutep Limited
01-Jun-2020 Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up Almac Group
01-Jun-2020 Orgenesis to collaborate with The Edith Wolfson Medical Center to conduct clinical study using Orgenesis’ proprietary POCare technologies for the generation and expansion of Tumor Infiltrating Lymphocytes Orgenesis Inc
29-May-2020 Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations Chi-Med
29-May-2020 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
29-May-2020 Interim analysis presented at the American Society of Clinical Oncology (ASCO) Annual Meeting London’s Global University
28-May-2020 Peli BioThermal Expands Global Rental Network in Incheon, South Korea Peli BioThermal
28-May-2020 Nordic Nanovector ASA: Results for the First Quarter 2020 Nordic Nanovector
28-May-2020 Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab Hutchison China MediTech Limited
28-May-2020 Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration Sanofi